Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer

Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer

Shiqiang Wang,1,2 Chongling Hu,2 Fei Xie,3 Yanhui Liu1 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China; 2Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing Univers...

Full description

Bibliographic Details
Main Authors: Wang S, Hu C, Xie F, Liu Y
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:OncoTargets and Therapy
Subjects:
immunotherapy
blood–brain barrier
brain metastasis
lung cancer
pd-1/pd-l1 inhibitors
Online Access:https://www.dovepress.com/use-of-programmed-death-receptor-1-andor-programmed-death-ligand-1-inh-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/use-of-programmed-death-receptor-1-andor-programmed-death-ligand-1-inh-peer-reviewed-article-OTT

Similar Items